Research Article

A possible Etiology and new treatment of Burning Mouth Syndrome and allied condition

Sudhakar Pattanaik*

Published: 06/27/2017 | Volume 1 - Issue 1 | Pages: 001-005


Introduction: Burning mouth syndrome, oral sub mucous fibrosis, leukoplakia, etc are the different manifestations of a common disease as per the surmise of various authors. There is no known cause and no specific treatment. Attempt is made in this study to find a cause and if possible, a treatment.

Materials and methods: 38 such cases were taken up in this study. It was found, that the cardinal signs of paucibacillar indeterminate form of Hanseniasis, as per the definition of WHO, are present in all these cases. Also they are found to respond well to the anti-leprotic drugs prescribed by WHO for the Hanseniasis.

Conclusion: It is recommended for multicentre trial and further research on this score which would relieve the suffering millions of the world populations.

Read Full Article HTML DOI: 10.29328/journal.ated.1001001 Cite this Article


  1. Zakzewaska JM. The burning mouth syndrome remains an enigma. Pain. 1995; 62: 253-257. Ref.:
  2. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. American Family Physician. 2002; 65: 615-620. Ref.:
  3. Macaron N, Arbiser J, Howard A. Oral sub mucous fibrosis. E Medicine July. 2003; 21: 1-15.
  4. Lee CH, Ko YC, Huang HL, Chao YY, Tsai CC, et al. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucoucous fibrosis in southern Taiwan. British Journal of cancer. 2003; 88: 366 -372. Ref.:
  5. Gopinath DV, Thappa DM, Jaishankar TJ. A clinical study of the involvement of cranial nerves in leprosy. Indian J Lepr. 2004; 76: 1-9. Ref.:
  6. Pattanaik S. Interesting obserbations on Primary Atrophic Rhinitis. Indian Journal of Otolaryngology and Head and Neck surgery. 2006; 58: 264-267. Ref.:
  7. WHO. Expert Committee on Leprosy: seventh Report. WHO tech rep ser No. 847 World Health Organization. Geneva. 1998. Ref.:   
  8. WHO. Report of the consultation on the early diagnosis of leprosy. Geneva. 1990; 90.2: 11-12. Ref.:
  9. WHO. Chemotherapy of leprosy for control programmes. WHO Tech Rep Ser No. 675. World Health Organization, Geneva. 1982; Ref.:
  10. Tzourio C, Henry P, Boucher P, Parent M, Millan J, et al. Lepre Lepromateuse: arguments cliniquee et electrophysiologiques en favour d’ une multineverite axonel. Acta leprol. 1989; 7: 51-56. Ref.:
  11. Grimaud J, Blum L, Verchaud B, Diop A, Millan J. Depster et surveillar une neuropathiie Hansenienne: queitestcoisir? Acta Leprol. 1992; 8: 17-22. Ref.:
  12. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev. 2005; 25: Ref.: